Sygnature Discovery appoints VP of Business Development – North America

Plans to expand customer base in the US and Canada over next two years

Sygnature Discovery, a provider of integrated drug discovery services, has appointed Craig Loftus to the newly created role of vice president, Business Development – North America.

Loftus is an experienced business developer with more than 27 years of sales experience in pharmaceutical and chemical outsourcing. Most recently he was director, New Business Development – UK and US at Onyx Scientific.

Sygnature Discovery has a number of long-term clients in San Francisco, San Diego and Boston and has ambitious plans to expand its customer base in the next two years. Loftus will be instrumental in promoting Sygnature’s drug discovery capabilities and expertise across the US and Canada, with a particular focus on fully integrated drug discovery projects.

Companies